Carcinoma of the vulva: Combined modality treatment

被引:7
作者
Montana G.S. [1 ]
机构
[1] Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710
关键词
Sentinel Node Biopsy; Radiat Oncol Biol Phys; Inguinal Node; Vulvar Cancer; Combine Modality Treatment;
D O I
10.1007/s11864-004-0041-3
中图分类号
学科分类号
摘要
One of the most significant developments in recent decades in the management of malignant diseases is the recognition that surgery, radiation, and chemotherapy have limited curative potential. Along with this recognition has come the realization that although some patients can be cured with one of these modalities alone, the judicious combination of these modalities can result in better outcome. Carcinoma of the vulva, a disease that presents challenges with its management because of its anatomic location, affinity for spread to the lymph nodes, and incidence in elderly patients, tends itself to the use of this multimodality approach. The specific purpose of this approach is to decrease the sequelae of radical surgery. In addition, patients that could not be considered candidates for any treatment, such as patients with unresectable nodes, can be offered therapy with potential of cure. The patients with moderately or very advanced disease should be considered for the combination of chemotherapy, radiation, and surgery. This combined therapy results in better outcome with lesser morbidity. The studies that have been carried out in recent years for patients with advanced carcinoma of the vulva have helped to establish treatment guidelines that can be followed with confidence until more information becomes available. Copyright © 2004 by Current Science Inc.
引用
收藏
页码:85 / 95
页数:10
相关论文
共 36 条
  • [1] Ries L.G., Pollack E.S., Young Jr. J.L., Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79, J. Natl. Cancer Inst., 70, pp. 693-707, (1983)
  • [2] van der Velden J., van Lindert A.C., Gimbrere C.H., Et al., Epidemiologic data on vulvar cancer: Comparison of hospital with population-based data, Gynecol. Oncol., 62, pp. 379-383, (1996)
  • [3] Sturgeon S.R., Brinton L.A., Devesa S.S., Kurman R.J., In situ and invasive vulvar cancer incidence trends (1973 to 1987), Am. J. Obstet. Gynecol., 166, pp. 1482-1485, (1992)
  • [4] Abell M.R., Goslin J.R., Intraepithelial and infiltrative carcinoma of vulva: Bowen's type, Cancer, 14, pp. 318-329, (1961)
  • [5] Choo Y.C., Morley G.W., Double primary epidermoid carcinoma of the vulva and cervix, Gynecol. Oncol., 9, pp. 324-333, (1980)
  • [6] Pilotti S., Rotola A., D'Amato L., Et al., Vulvar carcinomas: Search for sequences homologous to human papillomavirus and herpes simplex virus DNA, Mod. Pathol., 3, pp. 442-448, (1990)
  • [7] Perez C.A., Grigsby P.W., Brady L.W., Principles and Practice of Radiation Oncology, (1997)
  • [8] Homesley H.D., Bundy B.N., Sedlis A., Adcock L., Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes, Obstet. Gynecol., 68, pp. 733-740, (1986)
  • [9] de Hullu J.A., Hollema H., Piers D.A., Et al., Sentinel lymph node procedure is highly accurate in squamous cell carcinoma of the vulva, J. Clin. Oncol., 18, pp. 2811-2816, (2000)
  • [10] Taussig F.J., Cancer of the vulva: An analysis of 155 cases (1911-1940), Am. J. Obstet. Gynecol., 40, pp. 764-769, (1948)